"was all the recent price rise simply a reaction to the
August?
It was only really moving back to where it was prior to '13, this year prices has steadily declined with the falling price of copper which has now turned around and the sub holder exiting earlier this year gone.
I think the price rise had numerous backers behind it aside from simply regaining ground - corporate update end of june followed by Los Calatos optimisation last week and the CG IB's restated price target -
> Company remains focussed on Los Calatos & in discussion with partners.
> optimisation study significantly improves economics
> Mollacas in Chile final met test work and looking for partner or outright sale
> $12M cash and funded well into 2015
> Current developments in Peru Cu space - the price Glencore is going to fetch for Los Bamas sale $5-7B & AngloAmerican's move on $3B Quellaveco construction
> Cannacord Genuitys restated $0.32 target last week after the improved economica where released
- Forums
- ASX - By Stock
- london 20.8
"was all the recent price rise simply a reaction to the...
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.648M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $1.5K | 150K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 967474 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3284661 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 967474 | 0.010 |
12 | 9513794 | 0.009 |
15 | 6813451 | 0.008 |
9 | 6461893 | 0.007 |
9 | 5046665 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3284661 | 3 |
0.012 | 406020 | 3 |
0.013 | 500000 | 1 |
0.014 | 965428 | 3 |
0.015 | 151515 | 3 |
Last trade - 14.45pm 13/11/2024 (20 minute delay) ? |
Featured News
LCL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online